HK1066545A1 - Novel amlodipine camsylate and method for preparing thereof - Google Patents
Novel amlodipine camsylate and method for preparing thereofInfo
- Publication number
- HK1066545A1 HK1066545A1 HK04109527A HK04109527A HK1066545A1 HK 1066545 A1 HK1066545 A1 HK 1066545A1 HK 04109527 A HK04109527 A HK 04109527A HK 04109527 A HK04109527 A HK 04109527A HK 1066545 A1 HK1066545 A1 HK 1066545A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- amlodipine camsylate
- novel
- novel amlodipine
- camsylate
- Prior art date
Links
- UXKMFEPPKJZDAR-STOWLHSFSA-N [(1r,4s)-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid;3-o-ethyl 5-o-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl UXKMFEPPKJZDAR-STOWLHSFSA-N 0.000 title abstract 2
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 abstract 1
- 229960000528 amlodipine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2001-0016514A KR100452491B1 (ko) | 2001-03-29 | 2001-03-29 | 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법 |
| PCT/KR2002/000543 WO2002079158A1 (en) | 2001-03-29 | 2002-03-28 | Novel amlodipine camsylate and method for preparing thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1066545A1 true HK1066545A1 (en) | 2005-03-24 |
Family
ID=36792806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04109527A HK1066545A1 (en) | 2001-03-29 | 2004-12-01 | Novel amlodipine camsylate and method for preparing thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6936625B2 (de) |
| EP (1) | EP1373207B1 (de) |
| JP (1) | JP4188088B2 (de) |
| KR (1) | KR100452491B1 (de) |
| CN (1) | CN1238342C (de) |
| AT (1) | ATE498612T1 (de) |
| AU (1) | AU2002243069B2 (de) |
| BR (1) | BRPI0208468B8 (de) |
| CA (1) | CA2441613C (de) |
| CZ (1) | CZ304489B6 (de) |
| DE (1) | DE60239193D1 (de) |
| DK (1) | DK1373207T3 (de) |
| ES (1) | ES2360787T3 (de) |
| HK (1) | HK1066545A1 (de) |
| HU (1) | HU227919B1 (de) |
| IL (2) | IL158082A0 (de) |
| MX (1) | MXPA03008675A (de) |
| NZ (1) | NZ528362A (de) |
| PL (1) | PL207535B1 (de) |
| PT (1) | PT1373207E (de) |
| RU (1) | RU2241701C1 (de) |
| WO (1) | WO2002079158A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4287752B2 (ja) * | 2002-04-13 | 2009-07-01 | ハンリム ファーマシューティカル カンパニー リミテッド | アムロジピンニコチネート及びその製造方法 |
| KR20040011751A (ko) * | 2002-07-30 | 2004-02-11 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100496436B1 (ko) | 2002-07-30 | 2005-06-20 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100538641B1 (ko) * | 2002-07-30 | 2005-12-22 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100462304B1 (ko) * | 2002-07-30 | 2004-12-17 | 씨제이 주식회사 | 암로디핀의 유기산염 |
| KR100558505B1 (ko) * | 2003-01-27 | 2006-03-07 | 한미약품 주식회사 | 안정한 무정형 암로디핀 캠실레이트, 이의 제조방법 및이를 포함하는 경구투여용 조성물 |
| WO2005042485A1 (en) * | 2003-10-30 | 2005-05-12 | Sk Chemicals, Co., Ltd. | Acid added salts of amlodipine |
| KR100841409B1 (ko) * | 2003-12-16 | 2008-06-25 | 에스케이케미칼주식회사 | 암로디핀 겐티세이트 염과 이의 제조방법 |
| KR100632470B1 (ko) * | 2005-02-25 | 2006-10-12 | 민연식 | 결정성 시부트라민 캄실레이트염과 이의 제조방법 |
| KR100913791B1 (ko) * | 2006-07-21 | 2009-08-26 | 한미약품 주식회사 | (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물 |
| KR100830003B1 (ko) | 2006-10-31 | 2008-05-15 | 씨제이제일제당 (주) | 결정성 ｓ-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법 |
| KR100843401B1 (ko) * | 2006-12-04 | 2008-07-04 | 씨제이제일제당 (주) | 결정성 ｓ-(-)-암로디핀 캠실레이트 무수물 및 이의제조방법 |
| KR100840069B1 (ko) * | 2007-01-23 | 2008-06-20 | 씨제이제일제당 (주) | 결정성 ｓ-(-)-암로디핀 오로테이트 무수물 및 이의제조방법 |
| KR100799821B1 (ko) * | 2007-02-05 | 2008-01-31 | 동화약품공업주식회사 | 신규한 이마티닙 캠실레이트 및 그의 제조방법 |
| WO2010085014A1 (en) * | 2009-01-23 | 2010-07-29 | Hanmi Pharm. Co., Ltd. | Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same |
| PT3150610T (pt) | 2010-02-12 | 2019-11-11 | Pfizer | Sais e polrmorfos de 8-fluor0-2-{4- [(metilamino}metil]fenil}-1,3,4,5-tetrahidr0-6hazepin0[ 5,4,3-cd]indol-6-0na |
| US8415483B2 (en) | 2010-12-22 | 2013-04-09 | Astrazeneca Ab | Compounds and their use as BACE inhibitors |
| CN102266333B (zh) * | 2011-08-19 | 2012-08-29 | 海南锦瑞制药股份有限公司 | 一种含有左旋氨氯地平和阿托伐他汀钙的全新药用组合物及其制备方法 |
| WO2013054108A1 (en) | 2011-10-10 | 2013-04-18 | Astrazeneca Ab | Mono-fluoro beta-secretase inhibitors |
| US10548882B2 (en) * | 2012-06-21 | 2020-02-04 | Astrazeneca Ab | Camsylate salt |
| KR101910901B1 (ko) | 2013-11-29 | 2018-10-24 | 한미약품 주식회사 | 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제 |
| KR101914930B1 (ko) | 2015-03-31 | 2018-11-05 | 한미약품 주식회사 | 암로디핀, 로자탄 및 클로르탈리돈을 포함하는 약제학적 복합 제제 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| GB8608335D0 (en) * | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
| US6057344A (en) * | 1991-11-26 | 2000-05-02 | Sepracor, Inc. | Methods for treating hypertension, and angina using optically pure (-) amlodipine |
| KR100188391B1 (ko) | 1993-08-27 | 1999-06-01 | 류정열 | 전기자동차의 충전중 표시 장치 |
| KR100374405B1 (ko) * | 2000-06-21 | 2003-03-04 | 한국유나이티드제약 주식회사 | 암로디핀 베실레이트의 제조방법 |
| CA2433181C (en) * | 2000-12-29 | 2005-11-22 | Pfizer Limited | Amlodipine hemifumarate |
-
2001
- 2001-03-29 KR KR10-2001-0016514A patent/KR100452491B1/ko active IP Right Grant
-
2002
- 2002-03-28 PL PL362667A patent/PL207535B1/pl unknown
- 2002-03-28 AU AU2002243069A patent/AU2002243069B2/en not_active Expired
- 2002-03-28 HU HU0303639A patent/HU227919B1/hu unknown
- 2002-03-28 BR BRPI0208468A patent/BRPI0208468B8/pt not_active IP Right Cessation
- 2002-03-28 CN CNB028074432A patent/CN1238342C/zh not_active Expired - Lifetime
- 2002-03-28 DE DE60239193T patent/DE60239193D1/de not_active Expired - Lifetime
- 2002-03-28 CA CA002441613A patent/CA2441613C/en not_active Expired - Lifetime
- 2002-03-28 PT PT02708811T patent/PT1373207E/pt unknown
- 2002-03-28 EP EP02708811A patent/EP1373207B1/de not_active Expired - Lifetime
- 2002-03-28 AT AT02708811T patent/ATE498612T1/de active
- 2002-03-28 RU RU2003131687/04A patent/RU2241701C1/ru active
- 2002-03-28 DK DK02708811.1T patent/DK1373207T3/da active
- 2002-03-28 CZ CZ2003-2583A patent/CZ304489B6/cs not_active IP Right Cessation
- 2002-03-28 WO PCT/KR2002/000543 patent/WO2002079158A1/en active IP Right Grant
- 2002-03-28 MX MXPA03008675A patent/MXPA03008675A/es active IP Right Grant
- 2002-03-28 NZ NZ528362A patent/NZ528362A/en not_active IP Right Cessation
- 2002-03-28 ES ES02708811T patent/ES2360787T3/es not_active Expired - Lifetime
- 2002-03-28 IL IL15808202A patent/IL158082A0/xx unknown
- 2002-03-28 US US10/473,479 patent/US6936625B2/en not_active Expired - Lifetime
- 2002-03-28 JP JP2002577785A patent/JP4188088B2/ja not_active Expired - Lifetime
-
2003
- 2003-09-24 IL IL158082A patent/IL158082A/en unknown
-
2004
- 2004-12-01 HK HK04109527A patent/HK1066545A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1066545A1 (en) | Novel amlodipine camsylate and method for preparing thereof | |
| MY142029A (en) | Phenoxyacetic acid derivatives | |
| BG108318A (en) | Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| TNSN05194A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| NO20071577L (no) | Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer | |
| EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| JO2493B1 (en) | New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses | |
| MY128609A (en) | Ccr5 antagonists useful for treating aids. | |
| WO2002102787A3 (en) | Novel sulfonic acid derivatives | |
| NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| NO20055754L (no) | Kolkisosidanaloger | |
| HUP0600084A2 (en) | Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient | |
| WO2006074919A3 (de) | 3 -AMINO- 6-ARYL (BZW.6-HETEROARYL) -THIENO [2 , 3-B] PYRIDIN-2-CARBONSÄUREAMIDE, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN UND IHRE VERWENDUNG ALS INHIBITOREN DER TNFα-FREISETZUNG | |
| WO2002072567A3 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| ATE491686T1 (de) | Amlodipin-gentisat und verfahren zu dessen herstellung | |
| WO2001081298A3 (en) | Cyclic carboxylic acids as integrin antagonists | |
| AU2003256108A1 (en) | Organic acid salt of amlodipine | |
| DE60335960D1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung | |
| WO2003004460A3 (en) | Succinic acid derivatives | |
| WO2002030874A3 (en) | Aliphatic, cyclic amino carboxylic acids as integrin antagonists | |
| WO2003013530A3 (de) | Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten | |
| WO2002030876A3 (en) | Cyclic carboxylic acids as integrin antagonists | |
| WO2004000206A3 (en) | Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same | |
| EA200100156A2 (ru) | Новые производные 6-сульфамоил-3-хинолилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20220327 |